Hear several experts address systematic literature review issues that can negatively affect your Global Value Dossiers (GVDs) and how automation can improve your product's market access.
As payers demand more robust frameworks for assessing new products, an evidence-based research methodology for conducting literature reviews powered by automation software will set your company's Global Value Dossier (GVD) apart and improve team productivity, accuracy, and transparency.
GVDs are critically important in presenting the product value story and achieving market access. Are you confident your GVD and associated systematic literature review (SLR) is thorough, accurate, and transparent? Can the GVD or SLR easily update with the latest research without requiring a large team and duplicative work? Can global and remote stakeholders gain the level of access they need to the reviewed literature? This webinar addresses systematic literature review issues that can quickly derail your GVD, slowing down your product's market access. You'll learn how literature review automation software can help you avoid redundant, error-prone work, utilize automation for faster and more accurate outputs, and create reproducible, centralized results.
Presenters
Gillian Sibbring
Gillian Sibbring has dedicated the last 20 years of her HEOR and Market Access consultancy career to refining and streamlining the process of SLR and GVD development, to meet Pharma client objectives within realistic timeframes and budgets.
Sue O'Leary
Sue O'Leary heads up the Evidence and Access team at Prime Global, supporting Pharma clients across the life cycle, to make sure that evidence is optimal not just for launch but beyond. Making sure global dossiers and value stories are underpinned by an understanding of local needs and relatable evidence is key to the development of an optimal GVD.
Ben Rousseau
Ben Rousseau is a Senior Director at Adelphi Values PROVE™ where he heads up the Technology and Commercialization team. Ben has nearly 30 years of experience across multiple agencies and consultancies, with over half of this time spent in medical communications prior to making the move to Market Access and HEOR where he has a specific interest in innovative communication solutions.
Patti Peeples
Patti is a health economist, pharmacist and industry leader with 35 years of experience in health care value, evidence and access.
Rachel Forrest
As a key Account Manager at DistillerSR, Rachel Forrest prioritizes customer satisfaction through her almost 25-year background in dental practice leadership and project management, executive-level administration, software sales, and customer experience management.
Sponsor
DistillerSR
Content Partners
HealthEconomics.com
HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.
HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.
Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.
